OVERVIEW The large molecules that constitute biopharmaceuticals differ from small molecules not only in their size but also in behavior, manufacture, and action in the human body. Manufacturing these molecules is significantly more complex than producing traditional pharmaceuticals. Despite the industry’s high complexity, however, outsourcing has become extremely popular. Not surprisingly, global contract manufacturing organizations (CMO) sales are growing steadily, fed not only by increased outsourcing but by overall growth in new and existing products, including clinical-trial supply. Contract manufacturing in the biopharmaceutical industry involves drug product manufacturing services on a fee-for-service basis for biopharmaceuticals, including formulation, fill, packaging and labeling, lyophilization, and other services related to the final production of the biopharmaceutical drug product. For biopharma companies requiring manufacturing capabilities and experience, partnering with a vaccine or biologics-focused contract manufacturing organization is likely to bring several advantages.

 1 RESEARCH METHODOLOGY 

2 RESEARCH OBJECTIVES 

3 RESEARCH PROCESS 

4 SCOPE & COVERAGE

5 REPORT ASSUMPTIONS & CAVEATS 

6 MARKET AT A GLANCE 

7 INTRODUCTION 

8 MARKET OPPORTUNITIES & TRENDS 

9 MARKET GROWTH ENABLERS 

10 MARKET RESTRAINTS

11 MARKET LANDSCAPE